RE: another usual red day8 Jun 2020 10:59
Why even go down the Covid route if they didn't feel COPD and Covid would both be effective. Past experiences, lab results and more importantly IMO working with Professor Tom Wilkinson have lead them to the Covid trials.
Many of the trials out there are straw grasping and using products which have never been used on any form of coronavirus let alone lung infections etc.
I think it's also worth re-reading the following statements about our covid trial too:
'Professor Tom Wilkinson, Professor of Respiratory Medicine at the University of
Southampton and Trial Chief Investigator, commented: “We are facing an
unprecedented health challenge with COVID-19 which desperately requires the rapid
development of new therapeutic strategies. There are a limited number of candidate
new treatments available and so it is vital we can rapidly generate high quality evidence
on the role of these in COVID-19 patients. The UK research delivery and regulatory
teams have worked incredibly effectively to enable this world leading trial to achieve
approvals so rapidly which has enabled our motivated and highly expert team of
researchers to get this vital study running straight away.”
Professor Stephen Holgate, Medical Research Council (MRC) Professor of
Immunopharmacology, commented: “The reduced innate immune response that
exists in the lung of those at most risk of serious COVID-19 disease such as older
people and those with pre-existing lung disease makes such patients ideal candidates
to receive inhaled SNG001 to replace their interferon deficiency. This is especially so
because SARS-CoV-2, along with MERS-CoV and SARS-CoV, is equipped to evade
this first line of viral defence. In the absence of a suitable vaccine, increasing the host’s
own immunity to enhance protection and virus elimination would seem a logical
therapeutic approach.”
Sign In
Follow the stocks
